» Articles » PMID: 14982938

Analysis of the VMD2 Promoter and Implication of E-box Binding Factors in Its Regulation

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Feb 26
PMID 14982938
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The retinal pigment epithelium (RPE) is crucial for the normal development and function of retinal photo-receptors, and mutations in several genes that are preferentially expressed in the RPE have been shown to cause retinal degeneration. We analyzed the 5'-up-stream region of human VMD2, a gene that is preferentially expressed in the RPE and, when mutated, causes Best macular dystrophy. Transgenic mouse studies with VMD2 promoter/lacZ constructs demonstrated that a-253 to +38 bp fragment is sufficient to direct RPE-specific expression in the eye. Transient transfection assays using the D407 human RPE cell line with VMD2 promoter/luciferase reporter constructs identified two positive regulatory regions, -585 to -541 bp for high level expression and -56 to -42 bp for low level expression. Mutation of a canonical E-box located in the -56 to -42 bp region greatly diminished luciferase expression in D407 cells and abolished the bands shifted with bovine RPE nuclear extract in electrophoretic mobility shift assays. Independently a candidate approach was used to select microphthalmia-associated transcription factor (MITF) for testing because it is expressed in the RPE and associated with RPE abnormalities when mutated. MITF-M significantly increased luciferase expression in D407 cells in an E-box-dependent manner. These studies define the VMD2 promoter region sufficient to drive RPE-specific expression in the eye, identify positive regulatory regions in vitro, and suggest that MITF as well as other E-box binding factors may act as positive regulators of VMD2 expression.

Citing Articles

Challenges in AAV-Based Retinal Gene Therapies and the Role of Magnetic Nanoparticle Platforms.

Siontas O, Ahn S J Clin Med. 2024; 13(23).

PMID: 39685843 PMC: 11642484. DOI: 10.3390/jcm13237385.


Clinical and genetic features in autosomal recessive bestrophinopathy in Chinese cohort.

Zhao D, Gu V, Wang Y, Peng J, Lyu J, Fei P BMC Ophthalmol. 2024; 24(1):308.

PMID: 39048936 PMC: 11267682. DOI: 10.1186/s12886-024-03574-8.


SIRT6 overexpression in the nucleus protects mouse retinal pigment epithelium from oxidative stress.

Yang X, Chung J, Rai U, Esumi N Life Sci Alliance. 2023; 6(7).

PMID: 37185874 PMC: 10130745. DOI: 10.26508/lsa.202201448.


Gene Therapy Activates Retinal Pigment Epithelium Cell Proliferation for Age-related Macular Degeneration in a Mouse Model.

Yuan Y, Kong W, Liu X, Shi G Curr Med Sci. 2023; 43(2):384-392.

PMID: 36944806 DOI: 10.1007/s11596-022-2684-3.


CRISPR/Cas9 mediated specific ablation of vegfa in retinal pigment epithelium efficiently regresses choroidal neovascularization.

Park J, Cui G, Lee H, Jeong H, Kwak J, Lee J Sci Rep. 2023; 13(1):3715.

PMID: 36878916 PMC: 9988861. DOI: 10.1038/s41598-023-29014-z.